Windlas Biotech (NSE:WINDLAS) Accounts Payable & Accrued Expense : ₹1,672 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Windlas Biotech Accounts Payable & Accrued Expense?

Windlas Biotech's quarterly accounts payable & accrued expense declined from Sep. 2024 (₹1,900 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹1,672 Mil).

Windlas Biotech's annual accounts payable & accrued expense increased from Mar. 2023 (₹991 Mil) to Mar. 2024 (₹1,466 Mil) and increased from Mar. 2024 (₹1,466 Mil) to Mar. 2025 (₹1,672 Mil).

Windlas Biotech Accounts Payable & Accrued Expense Historical Data

The historical data trend for Windlas Biotech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Windlas Biotech Accounts Payable & Accrued Expense Chart

Windlas Biotech Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

484.50

707.54

991.13

1,466.49

1,672.37

Windlas Biotech Quarterly Data
	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,466.49	-	1,900.08	-	1,672.37

Windlas Biotech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Windlas Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Windlas Biotech Ltd (NSE:WINDLAS) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

543329:India

Address

Golf Course Extension Road, 705-706, Vatika Professional Point, Sector-66, Gurgaon, HR, IND, 122 001

Website

https://www.windlas.com

Windlas Biotech Ltd is a pharmaceutical formulation contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.

Windlas Biotech Headlines

No Headlines